Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 21) ADC Therapeutics SA (NYSE:...

Horizon Therapeutics Named Number One Best Workplace in Chicago

01:15pm, Thursday, 21'st May 2020

Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named No. 1 on the Great Place to Work® "Best Workplaces in Chicago 2020" list in the small and medium category. The list incl

Horizon Therapeutics To Present Data On KRYSTEXXA At European Congress Of Rheumatology

12:07pm, Thursday, 21'st May 2020

Data on Multiple Immunomodulation Approaches with KRYSTEXXA® (pegloticase injection) to be Presented at the Annual European Congress of Rheumatology (EULAR 2020)

12:00pm, Thursday, 21'st May 2020

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that multiple case series and studies will be presented at the Annual European Congress of Rheumatology (EULAR 2020), being held virtually June

The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering

12:00am, Tuesday, 19'th May 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) ADC Therapeutics SA (NYSE:...

Stocks That Hit 52-Week Highs On Monday

02:44pm, Monday, 18'th May 2020

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Horizon Therapeutics Public Company Stock News

Edited Transcript of HZNP earnings conference call or presentation 6-May-20 12:00pm GMT

The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas

Horizon Therapeutics Plc (HZNP) EVP, Corporate Affairs, CCO Geoffrey M. Curtis Sold $–. ...

Stocks That Hit 52-Week Highs On Tuesday

B of A Securities Reiterates Buy on Horizon Therapeutics, Raises Price Target to $57

Stocks That Hit 52-Week Highs On Friday

The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray

Horizon Therapeutics Named Number One Best Workplace in Chicago

Horizon Therapeutics To Present Data On KRYSTEXXA At European Congress Of Rheumatology

Data on Multiple Immunomodulation Approaches with KRYSTEXXA® (pegloticase injection) to be Presented at the Annual European Congress of Rheumatology (EULAR 2020)

Stocks That Hit 52-Week Highs On Thursday

In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs

Horizon Therapeutics to Participate in Upcoming Investor Conferences

The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering

Stocks That Hit 52-Week Highs On Monday

Top Fintech Company